Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMCS.L Regulatory News (MCS)

  • There is currently no data for MCS

Directorate Change

31 Aug 2018 17:12

RNS Number : 4755Z
McCarthy & Stone PLC
31 August 2018
 

Friday, 31 August 2018

 

 

McCarthy & Stone plc

 

Board Changes

 

 

As contemplated by the announcements on 19 June 2018 and 28 June 2018, Clive Fenton has today retired as the Chief Executive Officer ("CEO"), and stepped down from the board, of McCarthy & Stone plc (the "Group") and John Tonkiss, Chief Operating Officer of the Group, has assumed the role of Interim CEO while the formal search process to appoint a replacement CEO is concluded.

 

 

Section 430 (2B) Companies Act 2006 Statement

The following payments have or will be made to Clive Fenton in connection with his retirement:

i) Clive will be paid £416,666.70 in respect of salary accrued up to 31 August 2018 but payable after that date in the normal pay round cycle.

ii) Clive will receive payments in lieu of 10 months' outstanding notice period and employer pension contributions in monthly instalments of £83,333.34 (total notice period of 12 months starting on 1 July 2018 and finishing on 30 June 2019).

iii) Clive will receive a bonus for the current financial year, to be paid in November 2018 and calculated by the Remuneration Committee according to the achievement of the relevant bonus performance measures. The bonus will be paid two-thirds in cash and one-third in deferred shares and will vest after 3 years.

iv) Clive will be treated as a 'good leaver' for the purpose of awards or allocations made to him under the Company's Annual and Deferred Bonus Plan, Long Term Incentive Plan, SAYE Plan and Share Incentive Plan. The awards will be treated accordingly under the rules of the relevant Plan.

v) Clive will also receive a capped contribution of up to £1,250 (plus VAT) towards legal fees incurred in connection with his cessation of office.

vi) Clive will receive outplacement support for 12 months after 31 August 2018.

All payments will be made in accordance with the Company's Directors' Remuneration Policy, as approved by shareholders at the Annual General Meeting of the Company held on 25 January 2017 less any deductions and withholdings for income tax and national insurance contributions required to be made.

The Company confirms that Clive Fenton has not and will not receive any other remuneration payments for loss of office of the type specified in section 430(2B) of the Companies Act 2006.

The relevant remuneration details relating to Clive Fenton will be included in the Company's Directors' Remuneration Report for the year ending 31 August 2018.

 

 

 

There is no additional information which is required to be disclosed pursuant to paragraph LR9.6.13R of the Listing Rules of the Financial Conduct Authority.

 

 

 

For more information, please contact:

McCarthy & Stone, 01202 292 480

Patrick Hole, Group General Counsel & Company Secretary

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOAWGUMURUPRGQG
Date   Source Headline
31st Jul 20208:23 amRNSDirectorate Change
29th Jul 20205:41 pmRNSHolding(s) in Company
15th Jul 20207:01 amRNSDirectorate Change
15th Jul 20207:00 amRNSHalf Year Results
3rd Jul 20209:00 amRNSNotice of Interim Results
22nd Jun 20204:11 pmRNSHolding(s) in Company
9th Jun 20204:18 pmRNSHolding(s) in Company
2nd Jun 20207:00 amRNSCOVID-19 Business Update
1st Jun 20209:30 amRNSDirector/PDMR Shareholding
28th May 202012:13 pmRNSDirector/PDMR Shareholding
19th May 20201:11 pmRNSDirector/PDMR Shareholding
12th May 20207:00 amRNSDirectorate Change
1st May 20207:00 amRNSTotal Voting Rights
1st May 20207:00 amRNSHolding(s) in Company
30th Apr 20205:56 pmRNSSale of assets to Waverstone LLP
29th Apr 20203:50 pmRNSDisclosure of Rights Attached to Equity Shares
7th Apr 202011:41 amRNSAdditional Listing
2nd Apr 20204:28 pmRNSDirector/PDMR Shareholding
27th Mar 20202:37 pmRNSHolding(s) in Company
25th Mar 202011:14 amRNSResults of Annual General Meeting
25th Mar 20207:00 amRNSAGM & Business Update
24th Mar 20201:37 pmRNSHolding(s) in Company
20th Mar 20204:17 pmRNSAnnual General Meeting and Covid-19
18th Mar 20204:42 pmRNSSecond Price Monitoring Extn
18th Mar 20204:37 pmRNSPrice Monitoring Extension
18th Mar 202010:56 amRNSCOVID-19 update
12th Mar 202011:44 amRNSHolding(s) in Company
2nd Mar 20209:14 amRNSTotal Voting Rights
19th Feb 202010:03 amRNSAnnual Financial Report
11th Feb 202010:22 amRNSDirector/PDMR Shareholding
7th Feb 20208:32 amRNSDirector/PDMR Shareholding
3rd Feb 20201:50 pmRNSHolding(s) in Company
3rd Feb 20209:16 amRNSBlock listing Interim Review
3rd Feb 20209:04 amRNSTotal Voting Rights
29th Jan 20203:45 pmRNSHolding(s) in Company
28th Jan 20207:00 amRNSFull Year Results
15th Jan 202010:40 amRNSDirector Declaration
13th Jan 20207:00 amRNSNotice of Results
10th Jan 20207:00 amRNSAppointment - General Counsel & Company Secretary
9th Jan 20202:35 pmRNSHolding(s) in Company
2nd Jan 202010:30 amRNSTotal Voting Rights
12th Dec 20199:12 amRNSDirectorate Change
15th Nov 20198:55 amRNSDirector/PDMR Shareholding
14th Nov 20198:06 amRNSHolding(s) in Company
13th Nov 20193:09 pmRNSHolding(s) in Company
7th Nov 20199:09 amRNSHolding(s) in Company
7th Nov 20197:00 amRNSFY19 Trading Update
1st Nov 20198:27 amRNSDirectorate Change
24th Oct 20198:05 amRNSHolding(s) in Company
22nd Oct 20193:17 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.